Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/22/2012US20120070487 Alkylsaccharide compositions with nutraceuticals
03/22/2012US20120070486 Methods and compositions related to prefoldin and its regulation
03/22/2012US20120070483 Multi-Functional Biocompatible Coatings for Intravascular Devices
03/22/2012US20120070480 Antimicrobial disposable absorbent articles
03/22/2012US20120070476 Compositions and Methods for Inactivation of Pathogens at Genital Tract Surfaces
03/22/2012US20120070475 Zero Calorie Polyphenol Aqueous Dispersions
03/22/2012US20120070474 Polymer compound for biomedical use and biochip substrate using such a polymer compound
03/22/2012US20120070473 Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions
03/22/2012US20120070472 Chronotherapeutic compositions and methods of their use
03/22/2012US20120070471 Administration of enoxoparin sodium to patients 75 years and older with st-segment elevation myocardial infarction
03/22/2012US20120070469 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
03/22/2012US20120070467 Ophthalmic Drug Delivery
03/22/2012US20120070465 Pharmaceutical composition for modified release
03/22/2012US20120070452 Immunoadjuvant composition and use thereof
03/22/2012US20120070451 Methods and compositions for modulating cardiac contractility
03/22/2012US20120070450 Leukemia stem cell markers
03/22/2012US20120070446 Rsv specific binding molecule
03/22/2012US20120070445 Brain-derived gonadotropins and cognition
03/22/2012US20120070443 Pde1 as a target therapeutic in heart disease
03/22/2012US20120070442 Methods and compositions for treating cancer
03/22/2012US20120070433 Flavonoid hydrogel
03/22/2012US20120070422 Method of Treating Ocular Disorders
03/22/2012US20120070417 Anti-influenza formulations and methods
03/22/2012US20120070415 Azido nucleosides and nucleotide analogs
03/22/2012US20120070413 Method of treating cancer with substituted amide derivatives
03/22/2012US20120070412 HCV Inhibitor and Therapeutic Agent Combinations
03/22/2012US20120070411 Substituted nucleotide analogs
03/22/2012US20120070410 Imidazolothiazole compounds and methods of use thereof
03/22/2012US20120070409 Tetracyclic fused heterocyclic compound and use thereof as hcv polymerase inhibitor
03/22/2012US20120070404 Increasing cancer patient survival time by administration of dithio-containing compounds
03/22/2012US20120070402 Polymeric artificial tear system
03/22/2012US20120070401 Composition and Method for Promoting Wound Healing
03/22/2012US20120070394 Methionine-derived peptidomimetics and their use in the protection of mitochondria of cutaneous cells
03/22/2012US20120070391 Cosmetic composition comprising an aqueous dispersion of polysiloxane/polyurea and a silane, cosmetic treatment process and kit therefor
03/22/2012US20120070390 Topical drug delivery system with dual carriers
03/22/2012US20120070386 Trehalulose-containing composition, its preparation and use
03/22/2012US20120070385 Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives
03/22/2012US20120070384 Topical antifungal composition
03/22/2012US20120070383 Polymeric nano-carriers with a linear dual response mechanism and uses thereof
03/22/2012US20120070380 Ingestible salt grabber
03/22/2012US20120070377 Compounds and biological materials and uses thereof
03/22/2012US20120070370 Spiro 1,3,4-thiadiazoline derivatives as ksp inhibitors
03/22/2012US20120070369 Hif inhibitors and use thereof
03/22/2012US20120070368 Methods of Using C-Met Modulators
03/22/2012DE102010047283B4 Untersuchungsverfahren/Screeningverfahren unter Einbeziehung von lebenden Geweben des Blutgefäß-Systems Investigation procedure / screening processes involving living tissues of the vascular system
03/22/2012DE102010045890A1 2,2'-Furoin-Derivte und deren Verwendung zur Hautaufhellung 2,2'-furoin-Derivte and the use thereof for lightening the skin
03/22/2012DE102010041117A1 Neue substituierte Amino-, Imino-1,2,4 Triazin Derivate New substituted amino, imino-1,2,4 triazine derivatives
03/22/2012DE102010040924A1 Substituierte Phenylacet- und Phenylpropanamide und ihre Verwendung Substituted Phenylacet- and Phenylpropanamide and their use
03/22/2012CA2812197A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure
03/22/2012CA2812195A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions
03/22/2012CA2812191A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases
03/22/2012CA2812184A1 Anthraquinone compounds and their uses
03/22/2012CA2812091A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012CA2812089A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012CA2812088A1 Phtalazine derivatives as jak1 inhibitors
03/22/2012CA2812087A1 Azabenzothiazole compounds, compositions and methods of use
03/22/2012CA2812081A1 Triazine-oxadiazoles
03/22/2012CA2812046A1 Modified irna agents
03/22/2012CA2812029A1 Prodrugs of guanfacine
03/22/2012CA2811559A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
03/22/2012CA2811526A1 Non-aqueous oily injectable formulation exhibiting preservative efficacy
03/22/2012CA2811525A1 Piperidinyl-substituted lactams as gpr119 modulators
03/22/2012CA2811501A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method
03/22/2012CA2811494A1 Octreotide-modified nanomedicine for cancer treatment or cancer palliative care
03/22/2012CA2811479A1 Pyridine compounds and the uses thereof
03/22/2012CA2811456A1 Pharmaceutical combination of resveratrol and progestin to treat and/or prevent myoma and/or endometriosis
03/22/2012CA2811285A1 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
03/22/2012CA2811265A1 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
03/22/2012CA2811258A1 Fulvestrant compositions and methods of use
03/22/2012CA2811242A1 Substituted phenylacetate and phenylpropane amides and use thereof
03/22/2012CA2811241A1 Terpenoid analogues and uses thereof for treating neurological conditions
03/22/2012CA2811228A1 Method for mobilizing stem and/or progenitor cells
03/22/2012CA2811202A1 Aqueous drug delivery system comprising off-flavor masking agent
03/22/2012CA2811186A1 High purity heparin and production method therefor
03/22/2012CA2811076A1 Pyrazine derivatives as enac blockers
03/22/2012CA2810708A1 Fused heteroaryls and their uses
03/22/2012CA2810702A1 Inhibitors of viral entry into mammalian cells
03/22/2012CA2810625A1 Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications
03/22/2012CA2810598A1 Pharmaceutical composition
03/22/2012CA2810524A1 Pharmaceutical compositions
03/22/2012CA2810254A1 Hsp90 inhibitors for treating non-small cell lung cancers in wild-type egfr and/or kras patients
03/22/2012CA2810094A1 Estrogen receptor modulators and uses thereof
03/22/2012CA2809793A1 Treatment of fungal infections
03/22/2012CA2809641A1 Pharmaceutical and nutraceutical compositions of abscisic acid
03/22/2012CA2809639A1 6-substituted demethyl-estradiol derivatives as selective er-beta agonists
03/22/2012CA2808530A1 Methods of reducing blood lactate concentration
03/22/2012CA2808246A1 Arylosulfonamides for the treatment of cns diseases
03/22/2012CA2807584A1 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
03/21/2012EP2431743A2 Cancer specific glycans and use thereof
03/21/2012EP2431477A1 Polyketide compound
03/21/2012EP2431473A1 Methods for genetic control of insect infestations in plants and compositions thereof
03/21/2012EP2431469A2 Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
03/21/2012EP2431466A1 Single-strand nucleic acid molecule for controlling gene expression
03/21/2012EP2431463A1 Test agent for visceral obesity and use thereof
03/21/2012EP2431405A1 Fine particles of crystalline polyol and method of preparing same
03/21/2012EP2431403A1 Polymer conjugate of bioactive substance having hydroxy group
03/21/2012EP2431393A1 Anti-axl antibody
03/21/2012EP2431385A2 Combination therapy with chlorotoxin
03/21/2012EP2431379A2 HCV inhibitors
03/21/2012EP2431377A1 Modified L-nucleic acids
1 ... 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 ... 7860